Trending News

Merck’s Keytruda Fails in Late-Stage HCC Trial

Merck’s vaunted PD-1 inhibitor Keytruda took a stumble in a late-stage trial as a treatment of patie
Read More

Vical slashes staff after culling phase II antifun

US biotech Vical is planning another round of job cuts after deciding to abandon its antifungal drug
Read More

Congressman aims to break pharma’s insulin ‘pricin

U.S. legislators have been introducing bills left and right proposing a variety of methods for bring
Read More

Danish Smallpox Vaccine Gets FDA Approval to Fight

This approval makes Bavarian Nordic’s vaccine the only approved vaccine in the world for preventing
Read More

Critical Cellular Player Controlling HIV Reproduct

Using genetic sequencing, scientists at the University of California, San Diego (UCSD), School of Me
Read More

€20M Series A Launches Cancer Immunotherapy Biotec

STipe Therapeutics was spun out from Aarhus University, Denmark, last year with a small grant, and h
Read More

Diabetes affects men and women differently: Everyt

According to the International Diabetes Federation, currently 42.5 crore people suffer from diabetes
Read More


;